SPONSORED CONTENT

Alniche Lifesciences forays into pharma manufacturing by setting up EffiKasia Lifesciences, a state-of-the-art manufacturing unit

January 02, 2021 23:30 IST
Tennis player James Blake
Management Team of Effikasia Lifesciences - L-R: Sumant Vir Kapoor (Director), Girish Arora (Managing Director), and Karan Arora (Director)

New Delhi [India], January 2 (ANI/NewsVoir): In this new year, Alniche Lifesciences has achieved a new milestone by venturing into manufacturing in its state-of-the-art facility under the name of EffiKasia Lifesciences at Kangra, Himachal Pradesh.

EffiKasia Lifesciences will manufacture pharmaceuticals, nutraceuticals and dermatologicals. With this initiative, Alniche plans to increase its profit margins and push top-line by expanding sales operations for Exports in semi-regulated markets. Additionally, with its own manufacturing setup, the company plans to compete in the institutional tender business thus setting up a new business vertical.

EffiKasia is in discussions with various global companies to acquire unique technology platform and by leveraging these technologies, the team of scientists in its R & D will introduce a whole new range of differentiated formulations in the domestic and exports markets. In the future, the Company plans to expand its manufacturing capacities to contract-manufacture for others, thus making its mark in the CMO space.

In aggressively growing and highly competitive IPM, Alniche Lifesciences has carved out its 70th rank by building brands in niche therapies - Nephrology, Critical care, Gastroenterology, Skinceuticals, Advance woundcare and Neurology segments.

The Company has bagged one of the top ranks in Nephrology and Critical Care segment. With its entire product range focused on Test-Treat-Rehabilitate, Alniche has registered double digit growth till December 2020.

"With our growing sales across various therapy-verticals, there has always been a need for back-end integration by setting up our manufacturing plant. Initially, EffiKasia will manufacture exclusively for Alniche and in the future expand its base as a reliable contract-manufacturing company," said Girish Arora, Founder & Managing Director of Alniche.

Karan Arora, Director - EffiKasia, shares the same vision and plans to expand the network of distributors for export markets. His vision is to bring newer technologies and manufacturing of global brands in India to produce high-quality products at competitive prices for the Indian masses.

He strongly believes that together with marketing edge of Alniche and manufacturing excellence of EffiKasia, this duo will create their mark in the domestic and exports markets.

Alniche Life Sciences is one of India's fastest growing Pharma Company based in New Delhi, serves patients and the medical fraternity by offering specialized, high-quality, effective, affordable medicines and wellness products.

Alniche has carved a firm position for itself in the Indian Pharma market through a focused approach for key brands and deep engagement with doctors. Their 700 sales team members are covering 70,000 doctors and 30,000 hospitals with a strong portfolio of both domestic and licensed brands from global partners, in the areas of Nephrology, Critical care, Gastroenterology, Dermatology, Neurology and Advanced wound care.

Alniche is ranked one of the top company in Renal care and Critical care. Alniche has partnered with global pharma organizations to bring novel global brands in India including Alliance (UK), J W Life Science (Korea), Adhezion Biomedical Inc. (USA), FzioMed (USA), PT Dermozone Pratama (Indonesia), Biovite (Australia), and Dongkook (Korea).

This story is provided by NewsVoir. ANI will not be responsible in any way for the content of this article. (ANI/NewsVoir)

DISCLAIMER


(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

 

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Alniche Lifesciences forays into pharma manufacturing by setting up EffiKasia Lifesciences, a state-of-the-art manufacturing unit

New Delhi [India], January 2 (ANI/NewsVoir): In this new year, Alniche Lifesciences has achieved a new milestone by venturing into manufacturing in its state-of-the-art facility under the name of EffiKasia Lifesciences at Kangra, Himachal Pradesh.

EffiKasia Lifesciences will manufacture pharmaceuticals, nutraceuticals and dermatologicals. With this initiative, Alniche plans to increase its profit margins and push top-line by expanding sales operations for Exports in semi-regulated markets. Additionally, with its own manufacturing setup, the company plans to compete in the institutional tender business thus setting up a new business vertical.

EffiKasia is in discussions with various global companies to acquire unique technology platform and by leveraging these technologies, the team of scientists in its R & D will introduce a whole new range of differentiated formulations in the domestic and exports markets. In the future, the Company plans to expand its manufacturing capacities to contract-manufacture for others, thus making its mark in the CMO space.

In aggressively growing and highly competitive IPM, Alniche Lifesciences has carved out its 70th rank by building brands in niche therapies - Nephrology, Critical care, Gastroenterology, Skinceuticals, Advance woundcare and Neurology segments.

The Company has bagged one of the top ranks in Nephrology and Critical Care segment. With its entire product range focused on Test-Treat-Rehabilitate, Alniche has registered double digit growth till December 2020.

"With our growing sales across various therapy-verticals, there has always been a need for back-end integration by setting up our manufacturing plant. Initially, EffiKasia will manufacture exclusively for Alniche and in the future expand its base as a reliable contract-manufacturing company," said Girish Arora, Founder & Managing Director of Alniche.

Karan Arora, Director - EffiKasia, shares the same vision and plans to expand the network of distributors for export markets. His vision is to bring newer technologies and manufacturing of global brands in India to produce high-quality products at competitive prices for the Indian masses.

He strongly believes that together with marketing edge of Alniche and manufacturing excellence of EffiKasia, this duo will create their mark in the domestic and exports markets.

Alniche Life Sciences is one of India's fastest growing Pharma Company based in New Delhi, serves patients and the medical fraternity by offering specialized, high-quality, effective, affordable medicines and wellness products.

Alniche has carved a firm position for itself in the Indian Pharma market through a focused approach for key brands and deep engagement with doctors. Their 700 sales team members are covering 70,000 doctors and 30,000 hospitals with a strong portfolio of both domestic and licensed brands from global partners, in the areas of Nephrology, Critical care, Gastroenterology, Dermatology, Neurology and Advanced wound care.

Alniche is ranked one of the top company in Renal care and Critical care. Alniche has partnered with global pharma organizations to bring novel global brands in India including Alliance (UK), J W Life Science (Korea), Adhezion Biomedical Inc. (USA), FzioMed (USA), PT Dermozone Pratama (Indonesia), Biovite (Australia), and Dongkook (Korea).

This story is provided by NewsVoir. ANI will not be responsible in any way for the content of this article. (ANI/NewsVoir)

DISCLAIMER


(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22